Ginkgo Bioworks acquires Reverie Labs’ AI/ML assets to revolutionize biosecurity and drug discovery
In a strategic move to solidify its position as a leader in cell programming and biosecurity, Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) has announced the acquisition of key assets from Reverie Labs, a company renowned for leveraging artificial intelligence and machine learning (AI/ML) to expedite drug discovery processes. This acquisition includes Reverie Labs’ infrastructure, software […]